Cart
sales@molnova.com
Home -
Products -
Others -
Other Targets -
2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]amino}acetic acid
2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]amino}acetic acid
CAS No. 2377032-39-6
2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]amino}acetic acid( trifluoroacetic acid )
Catalog No. M28425 CAS No. 2377032-39-6
trifluoroacetic acid is a chemical compound.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 100 | Get Quote |
|
| 5MG | 154 | Get Quote |
|
| 10MG | 230 | Get Quote |
|
| 25MG | 394 | Get Quote |
|
| 50MG | 582 | Get Quote |
|
| 100MG | 827 | Get Quote |
|
| 500MG | 1674 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]amino}acetic acid
-
NoteResearch use only, not for human use.
-
Brief Descriptiontrifluoroacetic acid is a chemical compound.
-
Descriptiontrifluoroacetic acid is a chemical compound.
-
In Vitro——
-
In Vivo——
-
Synonymstrifluoroacetic acid
-
PathwayOthers
-
TargetOther Targets
-
RecptorApoptosis inducer
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2377032-39-6
-
Formula Weight445.307
-
Molecular FormulaC17H14F3N3O8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC(=O)C(F)(F)F.OC(=O)CNc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Xiaoyan Gao, et al. Ozone initiated heterogeneous oxidation of unsaturated carboxylic acids by ATR-FTIR spectroscopy. Spectrochim Acta A Mol Biomol Spectrosc. 2019 May 5;214:177-183.
molnova catalog
related products
-
(S)-OSMI 3
(S)-OSMI 3 (Ent-OSMI-3) has anti-inflammatory and anti-tumour activity and can be used to study diabetes and neurodegenerative diseases.
-
WZ3146
WZ3146 is a mutant-selective irreversible inhibitor of EGFR(L858R) and EGFR(E746_A750) with IC50 of 2 nM and 2 nM; does not inhibit ERBB2 phosphorylation (T798I).
-
Bruceoside A
Bruceoside A could be transformed into the potent anticancer component brusatol in vivo, rather than its direct deglycosylated metabolite bruceosin.
